Pill with imprint R 029 is Orange, Round and has been identified as Alprazolam 0.5 mg. It is supplied by Actavis.
Alprazolam is used in the treatment of Anxiety; Panic Disorderand belongs to the drug class benzodiazepines.There is positive evidence of human fetal risk during pregnancy.Alprazolam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for R 029
Alprazolam
- Imprint
- R 029
- Strength
- 0.5 mg
- Color
- Orange
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Benzodiazepines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Actavis
- Inactive Ingredients
- silicon dioxide, corn starch, docusate sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium benzoate, FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00228-2029 | Actavis Pharma, Inc. |
| 00904-5859(Discontinued) | Major Pharmaceuticals |
| 67544-0419 | Prepak Systems Inc. (repackager) |
| 33358-0015 | CorePharma, LLC (repackager) |
Drug UsesAdd to Drug ListPrint
Get help with Imprint Code FAQs.
Related images for "R 029"
More about alprazolam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,465)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: benzodiazepines
- Breastfeeding
- En español
Patient resources
- Alprazolam drug information
- Alprazolam Extended-Release Tablets
- Alprazolam Orally Disintegrating Tablets
- Alprazolam Tablets
- Alprazolam Oral Solution
Other brands
Xanax, Xanax XR, Alprazolam Intensol, Niravam
Professional resources
- Alprazolam monograph
- Alprazolam (FDA)
- Alprazolam Extended Release (FDA)
- Alprazolam ODT (FDA)
- Alprazolam XR (FDA)
Other brands
Xanax, Xanax XR, Alprazolam Intensol, Niravam
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circ*mstances.
